Skip to main content
OpenTrials

Clinical trial condition

Follicular Lymphoma

Explore clinical trials studying Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

231 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Follicular Lymphoma trial results

Active, Not Recruiting

Personalized Risk Stratification Model of Follicular Lymphoma Patients

NCT03436602

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Arcispedale Santa Maria Nuova, AUSL IRCSS, Hematology Department Reggio Emilia, RE, Italy
  • Azienda Ospedaliera Universitaria Maggiore della Carità Novara, Italy
  • Institute of Oncology Research Bellinzona, Canton Ticino, Switzerland
  • Institute of Pathology Locarno, Canton Ticino, Switzerland
View Trial Details
Active, Not Recruiting

Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma

NCT03600441

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Advocate Medical Group - Park Ridge, Luther Lane - Oncology Park Ridge, Illinois, United States
  • Norton Cancer Institute - St. Matthews Campus Louisville, Kentucky, United States
  • Clinical Research Alliance Inc Lake Success, New York, United States
  • Manhattan Hematology Oncology Center New York, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

NCT04072458

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +40 more
Locations
  • Georgia Cancer Center Augusta, Georgia, United States
  • New York Medical College / Westchester Medical Center Valhalla, New York, United States
  • Sarah Cannon Research Institute/Tennesee Oncology Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy

NCT02889523

Conditions
DLBCL, Follicular Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU de Liege Liège, Belgium
  • CHRU Mont Godinne Yvoir, Belgium
  • Centre Hospitalier Victor Dupouy Argenteuil, France
View all 31 locations
View Trial Details
Active, Not Recruiting

Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A

NCT03245021

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Ballarat Health Ballarat, Victoria, Australia
  • Eastern Health Box Hill, Victoria, Australia
  • Monash Health Clayton, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View Trial Details

Related conditions